OraVax Incorporated

OraVax is engaged in the discovery, development and commercialization of vaccine and antibody products for the prevention and treatment of human infectious diseases. OraVax's products are vaccines that stimulate the body's own immunity to provide long term protection against disease, as well as antibody products that provide immediate passive immunity to treat existing infections or to protect against an acute disease risk. OraVax's focus has been on diseases of the mucosal surfaces and has been broadened to include a series of arboviral (insect borne) diseases addressable by single-dose live viral vaccines.

OraVax are planning to merge with Peptide Therapeutics plc.

Contact Details: 38 Sidney Street 4th Floor Cambridge MA 02139-4169 United States of America Tel: 617 526 6000 Fax: Email: WWW: www.avax.com/

Loading...

Recent Publications by OraVax Incorporated:
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. A chimeric yellow fever (YF)-dengue type 2 (dengue-2) virus...	6th July, 2000	OraVax, Inc., Cambridge,	J Virol. 2000 Jun;74(12):5477-85.
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. The heat-labile toxin (LT) of Escherichia coli is a potent mucosal...	17th June, 2000	OraVax, Inc., Cambridge,	Infect Immun. 2000 May;68(5):2775-82.
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. ChimeriVax-JE is a live, attenuated recombinant virus prepared by...	4th March, 2000	OraVax Inc., Cambridge,	J Virol. 2000 Feb;74(4):1742-51.

OraVax Incorporated Patents:
US Patent No.	Title
6709851	Stabilization of helicobacter urease
5538729	Oral treatment of helicobacter infection
5686270	Production of antigens by self-assembly of polypeptide components
5690938	Oral immunization with multiple particulate antigen delivery system
5733740	Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma
→View more OraVax Incorporated patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 522 times since April 2007, the link to the organisation's website has been followed 125 times

Recent Search Terms used to find this page: Oravax | oravax vaccine | Oravax | t | OraVax | Oravax | Oravax | OraVax inc. Cambridge | oravax vaccine | peptide therapeutics oravax merger | .

Search for more companies in Cambridge

Search for more companies in MA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for OraVax Incorporated